Butterfly Network, Inc.
A maker of handheld ultrasound devices that plug into a smartphone, Butterfly Network builds its whole-body imaging probes around a semiconductor chip rather than traditional lead-based crystals. Its products include the Butterfly iQ3, iQ+, and Butterfly Move, used by doctors, vets, and health systems. Founded in 2011 by DNA-sequencing pioneer Jonathan Rothberg, the company got its name partly from the butterfly-shaped signal-processing networks his team studied. Its compact probes are famously small enough to fit in a coat pocket.
Granted 377.8K · Sold 6.20M
Granted 377.8K · Bought 6.80M
Granted 9.51M · Bought 114.0K · Sold 963.6K
Granted 3.61M · Sold 433.1K
Granted 500.0K · Sold 99.2K
Granted 2.93M · Bought 50.0K · Sold 1.35M
Granted 2.03M · Sold 319.2K
Granted 1.57M · Sold 60.2K
Granted 1.32M · Sold 80.0K
Granted 1.14M · Sold 36.0K
Granted 255.6K · Sold 144.8K
Granted 333.3K · Sold 16.1K
Granted 377.8K · Bought 185.3K · Sold 60.0K
Granted 244.4K · Sold 16.7K
Granted 97.9K · Sold 166.2K
Granted 401.7K
Granted 377.8K
Granted 327.9K
Granted 89.4K · Sold 22.5K
Granted 244.4K · Sold 4.8K
Granted 352.3K · Sold 112.0K
Granted 48.2K
Granted 174.9K · Sold 1.9K
Granted 114.0K
Sold 16.7K
Granted 98.6K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Rothberg Jonathan MDirector, 10% owner · 34 transactions | — | 46.44M | 377.8K | — | 6.20M |
| Rothberg Jonathan M +1 co-filer10% owner, Director, 10% owner · 4 transactions | — | 36.84Mas of Mar 2022 | — | — | — |
| Robbins LarryDirector · 18 transactions | — | 23.82M | 377.8K | 6.80M | — |
| Devivo JosephPresident & CEO, Director · 12 transactions | — | 8.03M | 9.51M | 114.0K | 963.6K |
| Getz Heather CEVP, CFO & COO · 14 transactions | — | 2.92Mas of May 2025 | 3.61M | — | 433.1K |
| Fruchterman ToddPresident and CEO, Director · 3 transactions | — | 2.56Mas of Mar 2022 | 500.0K | — | 99.2K |
| Cashman SteveChief Business Officer · 14 transactions | — | 1.63M | 2.93M | 50.0K | 1.35M |
| Stoica Andrei GChief Technology Officer · 38 transactions | +2489.4% | 1.60Mas of Apr 2025 | 2.03M | — | 319.2K |
| Doherty John N.EVP, CFO · 4 transactions | — | 1.51M | 1.57M | — | 60.2K |
| Weiss Lawrence TCLO, GC and Corp Sec · 5 transactions | — | 1.24Mas of Jul 2023 | 1.32M | — | 80.0K |
| Ku VictorChief Technology Officer · 4 transactions | — | 1.10M | 1.14M | — | 36.0K |
| Shahida DariusChief Strategy/Bus Dev Officer · 7 transactions | — | 1.08Mas of Dec 2022 | 255.6K | — | 144.8K |
| Pugh StaceyChief Commercial Officer · 3 transactions | — | 808.6Kas of Mar 2022 | 333.3K | — | 16.1K |
| Phanstiel S. LouiseDirector · 7 transactions | — | 576.2K | 377.8K | 185.3K | 60.0K |
| Miller MaryGeneral Counsel & Corp Sec · 3 transactions | — | 522.6Kas of Mar 2022 | 244.4K | — | 16.7K |
| Carlson MeganCAO and SVP, Finance · 4 transactions | — | 507.2K | 97.9K | — | 166.2K |
| Schwartz EricaDirector · 6 transactions | — | 401.7K | 401.7K | — | — |
| Edelman Elazer RDirector · 5 transactions | +2502.3% | 392.9K | 377.8K | — | — |
| Dillon TamaraChief People Officer · 1 transaction | — | 327.9Kas of May 2022 | 327.9K | — | — |
| Caezza NicholasDeputy General Counsel · 6 transactions | — | 310.3K | 89.4K | — | 22.5K |
| Martin John DavidChief Medical Officer · 3 transactions | — | 286.5Kas of Feb 2023 | 244.4K | — | 4.8K |
| Carfora DawnDirector · 5 transactions | +1918% | 265.5K | 352.3K | — | 112.0K |
| Hammergren John HDirector · 1 transaction | +36.2% | 181.5Kas of Jun 2022 | 48.2K | — | — |
| Quander TroySVP, Regulatory and Quality · 5 transactions | — | 173.0Kas of Dec 2022 | 174.9K | — | 1.9K |
| Pettiti GianlucaDirector · 2 transactions | +1003.5% | 145.2Kas of Jun 2023 | 114.0K | — | — |
| Fielding StephanieChief Financial Officer · 2 transactions | — | 113.1Kas of Mar 2022 | — | — | 16.7K |
| Neubauer Caroll HDirector · 2 transactions | — | 98.6K | 98.6K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: -2.95M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.